Definigen Investors

Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.

Investors

Founded Date: 2012
Employee Number: 11-50
Industry: Healthcare Innovations
Investor Type: Healthcare Company
Number Of Exists: Venture - Series Unknown
Register and Claim Ownership